<h2>欧莱雅股票表现引发长期持有者的新疑问</h2>
<p>欧莱雅（ENXTPA:OR）近期股价下滑，过去一周股价下跌约 5%，过去三个月下跌约 9%，这引发了对当前估值的更深入关注。</p>
<p>查看我们对欧莱雅的最新分析。</p>
<p>在最新的股价为€355.6 时，欧莱雅最近 7 天的股价回报约为 5%，3 个月的股价回报约为 9%，这都表明动能减弱。这与 1 年总股东回报略微为负和 5 年总股东回报适度为正相一致。</p>
<p>如果这些变动让你重新考虑资金的投放方向，现在可能是扩大观察名单、查看 102 家顶级创始人领导公司的好时机。</p>
<p>因此，随着股价下滑并低于一些分析师的目标价，关键问题是欧莱雅是否暂时不受欢迎并提供价值，还是当前价格已经反映了其未来的增长潜力。</p>
<h2>最受欢迎的叙述：低估 12.4%</h2>
<p>欧莱雅以€355.6 收盘，而叙述的公允价值约为€406，价格与预期价值之间的差距引起了关注。</p>
<blockquote>
<p><em>对 Medik8 和 Color Wow 等收购的重大资本配置，以及数字或人工智能驱动的创新，预计将增强类别领导力，推动产品差异化，并提高未来收入和净利润率。全球 IT 转型和 BETiq 优化带来的运营效率正在推动持续的销售和管理费用及广告费用的控制，从而允许在高影响力的创新和新产品发布中进行再投资。这最终支持了运营利润率和未来的盈利增长。</em></p>
</blockquote>
<p>阅读完整叙述。</p>
<p>想看看这个高估值叙述背后有什么吗？它依赖于稳定的收入增长、更高的利润率和丰富的未来盈利倍数。想知道哪些具体预测支持接近€406 的公允价值和在竞争激烈的个人护理行业中更高的所需市盈率？完整叙述为你列出了数字并连接了各个点。</p>
<p><strong>结果：公允价值为€406.15（低估）</strong></p>
<p>完整阅读叙述，了解预测背后的内容。</p>
<p>然而，你仍然需要权衡风险，例如北亚和中国的竞争加剧，以及可能对利润率和增长预期施加压力的更高广告成本。</p>
<p>了解欧莱雅叙述的关键风险。</p>
<h2>另一种看法：倍数描绘了更严峻的图景</h2>
<p>虽然叙述的公允价值约为€406 暗示了上行空间，但当前的市盈率约为 31 倍，超过了同行的 27.3 倍和欧洲个人护理产品的平均 16.5 倍，尽管它非常接近公允比率 31.3 倍。这种与同行相比的溢价与接近公允比率的组合给你提出了一个简单的问题：这是你愿意支付的质量溢价，还是感觉有点薄的误差空间？</p>
<p>查看数字对这个价格的看法——在我们的估值分析中了解更多。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b72b2240-9517-437e-bf9d-13447d724ad4/chart/pe-multiple-vs-industry/query-ZGF0ZT0yMDI2LTA1LTE0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1640" height="650" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b72b2240-9517-437e-bf9d-13447d724ad4/chart/pe-multiple-vs-industry/query-ZGF0ZT0yMDI2LTA1LTE0"/></p>
<p>截至 2026 年 5 月的 ENXTPA:OR 市盈率</p>
<h2>下一步</h2>
<p>如果到目前为止的混合信号让你感到不确定，那本身就是一个有用的信号。迅速行动，审查数据，并通过查看两个关键回报来权衡潜在的上行空间。</p>
<h2>寻找更多投资想法？</h2>
<p>如果你对下一步该做什么犹豫不决，不要在一旁观望，让其他机会从你身边溜走。扩大你的搜索范围，比较替代方案。</p>
<ul>
<li>通过扫描结合优质基本面与吸引定价的公司，寻找潜在价值，使用 229 只高质量低估股票。</li>
<li>通过审查财务状况更强的公司，优先考虑韧性，使用稳健的资产负债表和基本面股票筛选器（392 个结果）。</li>
<li>通过检查包含 545 只高质量未被关注的潜力股的筛选器，寻找被忽视的机会。</li>
</ul>
<p><em>本文由 Simply Wall St 撰写，性质一般。<strong>我们基于历史数据和分析师预测提供评论，仅使用无偏见的方法，我们的文章不应被视为财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也不考虑你的目标或财务状况。我们的目标是为你提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
<h3><strong>新：AI 股票筛选器与提醒</strong></h3>
<p>我们的新 AI 股票筛选器每天扫描市场以发现机会。</p>
<p>• 分红强劲的公司（收益率 3%+）</p>
<p>• 内部人士购买的低估小盘股</p>
<p>• 高增长的科技和人工智能公司</p>
<p>或者从 50 多个指标中构建自己的筛选器。</p>
<p>立即免费探索</p>

欧莱雅(ADR)

<p>欧莱雅的股票最近在一周内下跌了 5%，在三个月内下跌了 9%，引发了对其估值的质疑。目前股价为 355.6 欧元，相较于 406 欧元的公允价值被认为是低估的。该公司正专注于收购和数字创新，以提升增长和利润率。然而，它面临来自竞争和广告成本上升的风险。目前的市盈率为 31 倍，高于同行，暗示投资者需要评估的溢价。分析建议投资者考虑替代方案，并评估市场中的潜在价值</p>

<h2>L'Oréal stock performance sets up fresh questions for long term holders</h2>
<div class="lb-trans"><h2>欧莱雅股票表现引发长期持有者的新疑问</h2>
</div><p>L'Oréal (ENXTPA:OR) has drifted lower recently, with the share price down around 5% over the past week and about 9% over the past 3 months, inviting a closer look at the current valuation.</p>
<div class="lb-trans"><p>欧莱雅（ENXTPA:OR）近期股价下滑，过去一周股价下跌约 5%，过去三个月下跌约 9%，这引发了对当前估值的更深入关注。</p>
</div><p>See our latest analysis for L'Oréal.</p>
<div class="lb-trans"><p>查看我们对欧莱雅的最新分析。</p>
</div><p>At the latest share price of €355.6, L'Oréal’s recent 7 day share price return of around 5% and 3 month share price return of about 9% both point to fading momentum. This aligns with a 1 year total shareholder return that is slightly negative and a modestly positive 5 year total shareholder return.</p>
<div class="lb-trans"><p>在最新的股价为€355.6 时，欧莱雅最近 7 天的股价回报约为 5%，3 个月的股价回报约为 9%，这都表明动能减弱。这与 1 年总股东回报略微为负和 5 年总股东回报适度为正相一致。</p>
</div><p>If these moves have you rethinking where to put fresh capital, it could be a good moment to broaden your watchlist and check out 102 top founder-led companies</p>
<div class="lb-trans"><p>如果这些变动让你重新考虑资金的投放方向，现在可能是扩大观察名单、查看 102 家顶级创始人领导公司的好时机。</p>
</div><p>So with the stock drifting and trading below some analyst targets, the key question now is whether L'Oréal is temporarily out of favour and offers value, or if the current price already reflects its future growth potential.</p>
<div class="lb-trans"><p>因此，随着股价下滑并低于一些分析师的目标价，关键问题是欧莱雅是否暂时不受欢迎并提供价值，还是当前价格已经反映了其未来的增长潜力。</p>
</div><h2>Most Popular Narrative: 12.4% Undervalued</h2>
<div class="lb-trans"><h2>最受欢迎的叙述：低估 12.4%</h2>
</div><p>With L'Oréal closing at €355.6 against a narrative fair value of about €406, the gap between price and projected worth has caught attention.</p>
<div class="lb-trans"><p>欧莱雅以€355.6 收盘，而叙述的公允价值约为€406，价格与预期价值之间的差距引起了关注。</p>
</div><blockquote>
<p><em>Major capital allocation to acquisitions such as Medik8 and Color Wow and digital or AI driven innovation is expected to increase category leadership, fuel product differentiation, and raise future revenue and net margins. Operational efficiencies from global IT transformation and BETiq optimization are driving sustained SG&amp;A and A&amp;P cost discipline, allowing for reinvestment in high impact innovation and launches. This ultimately supports both operating margin and future earnings growth.</em></p>
</blockquote>
<div class="lb-trans"><blockquote>
<p><em>对 Medik8 和 Color Wow 等收购的重大资本配置，以及数字或人工智能驱动的创新，预计将增强类别领导力，推动产品差异化，并提高未来收入和净利润率。全球 IT 转型和 BETiq 优化带来的运营效率正在推动持续的销售和管理费用及广告费用的控制，从而允许在高影响力的创新和新产品发布中进行再投资。这最终支持了运营利润率和未来的盈利增长。</em></p>
</blockquote>
</div><p>Read the complete narrative.</p>
<div class="lb-trans"><p>阅读完整叙述。</p>
</div><p>Want to see what sits behind that premium narrative? It leans on steady top line expansion, thicker margins, and a rich future earnings multiple. Curious which specific forecasts support a fair value near €406 and a higher required P/E in a competitive personal care sector? The full narrative lays out the numbers and joins the dots for you.</p>
<div class="lb-trans"><p>想看看这个高估值叙述背后有什么吗？它依赖于稳定的收入增长、更高的利润率和丰富的未来盈利倍数。想知道哪些具体预测支持接近€406 的公允价值和在竞争激烈的个人护理行业中更高的所需市盈率？完整叙述为你列出了数字并连接了各个点。</p>
</div><p><strong>Result: Fair Value of €406.15 (UNDERVALUED)</strong></p>
<div class="lb-trans"><p><strong>结果：公允价值为€406.15（低估）</strong></p>
</div><p>Have a read of the narrative in full and understand what's behind the forecasts.</p>
<div class="lb-trans"><p>完整阅读叙述，了解预测背后的内容。</p>
</div><p>However, you still need to weigh up risks such as tougher competition in North Asia and China, as well as higher advertising costs that could pressure margins and growth expectations.</p>
<div class="lb-trans"><p>然而，你仍然需要权衡风险，例如北亚和中国的竞争加剧，以及可能对利润率和增长预期施加压力的更高广告成本。</p>
</div><p>Find out about the key risks to this L'Oréal narrative.</p>
<div class="lb-trans"><p>了解欧莱雅叙述的关键风险。</p>
</div><h2>Another Take: Multiples Paint a Tougher Picture</h2>
<div class="lb-trans"><h2>另一种看法：倍数描绘了更严峻的图景</h2>
</div><p>While the narrative fair value of about €406 suggests upside, the current P/E of roughly 31x sits above both peers at 27.3x and the European personal products average at 16.5x, even though it is very close to a fair ratio of 31.3x. That mix of premium versus peers but near fair ratio raises a simple question for you: is this a quality premium you are comfortable paying, or a margin for error that feels a bit thin?</p>
<div class="lb-trans"><p>虽然叙述的公允价值约为€406 暗示了上行空间，但当前的市盈率约为 31 倍，超过了同行的 27.3 倍和欧洲个人护理产品的平均 16.5 倍，尽管它非常接近公允比率 31.3 倍。这种与同行相比的溢价与接近公允比率的组合给你提出了一个简单的问题：这是你愿意支付的质量溢价，还是感觉有点薄的误差空间？</p>
</div><p>See what the numbers say about this price — find out in our valuation breakdown.</p>
<div class="lb-trans"><p>查看数字对这个价格的看法——在我们的估值分析中了解更多。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b72b2240-9517-437e-bf9d-13447d724ad4/chart/pe-multiple-vs-industry/query-ZGF0ZT0yMDI2LTA1LTE0" alt="" original-src="https://images.simplywall.st/company/b72b2240-9517-437e-bf9d-13447d724ad4/chart/pe-multiple-vs-industry?date=2026-05-14"/></p>
<p>ENXTPA:OR P/E Ratio as at May 2026</p>
<div class="lb-trans"><p>截至 2026 年 5 月的 ENXTPA:OR 市盈率</p>
</div><h2>Next Steps</h2>
<div class="lb-trans"><h2>下一步</h2>
</div><p>If the mixed signals so far leave you unsure, that is a useful signal in itself. Move quickly, review the data, and weigh the upside yourself by checking the 2 key rewards</p>
<div class="lb-trans"><p>如果到目前为止的混合信号让你感到不确定，那本身就是一个有用的信号。迅速行动，审查数据，并通过查看两个关键回报来权衡潜在的上行空间。</p>
</div><h2>Looking for more investment ideas?</h2>
<div class="lb-trans"><h2>寻找更多投资想法？</h2>
</div><p>If you are hesitating on what to do next, do not sit on the sidelines while other opportunities pass you by. Widen your search and compare alternatives.</p>
<div class="lb-trans"><p>如果你对下一步该做什么犹豫不决，不要在一旁观望，让其他机会从你身边溜走。扩大你的搜索范围，比较替代方案。</p>
</div><ul>
<li>Target potential value by scanning companies that combine quality fundamentals with attractive pricing using the 229 high quality undervalued stocks.</li>
<li>Prioritise resilience by reviewing companies with stronger financial footing through the solid balance sheet and fundamentals stocks screener (392 results).</li>
<li>Hunt for underfollowed opportunities by checking the screener containing 545 high quality undiscovered gems.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过扫描结合优质基本面与吸引定价的公司，寻找潜在价值，使用 229 只高质量低估股票。</li>
<li>通过审查财务状况更强的公司，优先考虑韧性，使用稳健的资产负债表和基本面股票筛选器（392 个结果）。</li>
<li>通过检查包含 545 只高质量未被关注的潜力股的筛选器，寻找被忽视的机会。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>本文由 Simply Wall St 撰写，性质一般。<strong>我们基于历史数据和分析师预测提供评论，仅使用无偏见的方法，我们的文章不应被视为财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也不考虑你的目标或财务状况。我们的目标是为你提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div><h3><strong>New:</strong> AI Stock Screener &amp; Alerts</h3>
<div class="lb-trans"><h3><strong>新：AI 股票筛选器与提醒</strong></h3>
</div><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p>
<div class="lb-trans"><p>我们的新 AI 股票筛选器每天扫描市场以发现机会。</p>
</div><p>• Dividend Powerhouses (3%+ Yield)</p>
<div class="lb-trans"><p>• 分红强劲的公司（收益率 3%+）</p>
</div><p>• Undervalued Small Caps with Insider Buying</p>
<div class="lb-trans"><p>• 内部人士购买的低估小盘股</p>
</div><p>• High growth Tech and AI Companies</p>
<div class="lb-trans"><p>• 高增长的科技和人工智能公司</p>
</div><p>Or build your own from over 50 metrics.</p>
<div class="lb-trans"><p>或者从 50 多个指标中构建自己的筛选器。</p>
</div><p>Explore Now for Free</p>
<div class="lb-trans"><p>立即免费探索</p>
</div>

在近期股价疲软之后，评估欧莱雅 (ENXTPA:OR) 的估值